British Journal of Haematology · 2000 · 23 citations · 11 references
MedicineEndocrinologyOncologyPediatric EndocrinologyPediatric HematologyPediatric OncologyGrowth HormoneGrowth Hormone TherapyHematologic MalignanciesHormonal TherapyPediatric LeukemiasRadiation TherapyColonic AdenocarcinomaGrowth Hormone FamilyPituitary DwarfismSynergistic Impacts
Acromegaly patients are known to have an increased risk of malignancies, especially colonic adenocarcinoma. This may be as a result of the growth-stimulating effect of growth hormone (GH). The clustering of leukaemia in children treated with GH has also caused concern. There have been a few reports of leukaemia in acromegaly patients. We report two patients with acute lymphoblastic leukaemia and one patient with acute myeloid leukaemia among 106 acromegaly patients treated over a 15-year period. Two of the cases received radiotherapy as part of their treatment. Adjusted for age and follow-up years, the incidence of leukaemia in this cohort is significantly higher than the general population. The incidence is also higher than would be expected as a result of radiotherapy alone, suggesting that GH may play a synergistic role.
11
Increased incidence of neoplasia in patients with pituitary adenomas
Vera Popović, Svetozar Damjanović, Dragan Micić et al. · Clinical Endocrinology · 1998 · 201 citations
Medicine, Endocrinology, Oncology +12